Department of Error (DOI:10.1016/S0140-6736(09)61877-8);Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

The Lancet

Volumn 374, Issue 9707, 2009, Pages 2115-2122

  Black, Steven ^a   Eskola, Juhani ^b   Siegrist, Claire Anne ^c   Halsey, Neal ^d   MacDonald, Noni ^e   Law, Barbara ^f   Miller, Elizabeth ^g   Andrews, Nick ^g   Stowe, Julia ^g   Salmon, Daniel ^h   Vannice, Kirsten ^h   Izurieta, Hector S ⁱ   Akhtar, Aysha ⁱ   Gold, Mike ^j   Oselka, Gabriel ^k   Zuber, Patrick ^l   Pfeifer, Dina ^l   Vellozzi, Claudia ^m  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h Human Services   (United States)

ⁱ CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^j UNIVERSITY OF ADELAIDE   (Australia)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l WORLD HEALTH ORGANIZATION   (Switzerland)

^m CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BELL PALSY; DRUG FATALITY; DRUG SAFETY; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MORALITY; MORBIDITY; MULTIPLE SCLEROSIS; MYELITIS; NEURITIS; OPTIC NEURITIS; PANDEMIC; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; SIDE EFFECT; SPONTANEOUS ABORTION; SUDDEN DEATH;

EID: 72049119602     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60166-3     Document Type: Erratum

References (44)

1. CDC. Surveillance for safety after immunization: Vaccine Adverse Events Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 52 (2003) 1-24
2. Wakefield A.J. MMR vaccination and autism. Lancet 354 (1999) 949-950
3. Jansen V.A., Stollenwerk N., Jensen H.J., Ramsay M.E., Edmunds W.J., and Rhodes C.J. Measles outbreaks in a population with declining vaccine uptake. Science 301 (2003) 804
4. Kapp C. Nigerian states again boycott polio-vaccination drive. Lancet 363 (2004) 709
5. Löwer J. Two unclear cases of death. Can we still recommend HPV vaccination?. MMW Fortschr der Medizin 150 (2008) 6
6. Kokia E.S., Silverman B.G., Green M., Kedem H., Guindy M., and Shemer J. Deaths following influenza vaccination-background mortality or causal connection?. Vaccine 25 (2007) 8557-8561
7. Varricchio F., Iskander J., DeStefano F., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23 (2004) 287-294
8. Halsey N.A. The science of evaluation of adverse events associated with vaccination. Semin Pediatr Infect Dis 12 (2002) 205-214
9. Schonberger L.B., Bregman D.J., Sullivan-Boyyai J.Z., et al. Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol 110 (1979) 105-123
10. Dias-Tosta E., and Kückelhaus C.S. Guillain Barré syndrome in a population less than 15 years old in Brazil. Arq Neuropsiquiatr 60 (2002) 367-373
11. Klein N. Rates of autoimmune diseases in Kaiser Permanente for use in Vaccine Adverse Event safety studies. Presentation at National Foundation for Infectious Diseases meeting; Baltimore, MD, USA; April 29, 2009.
12. Warren S.A., Svenson L.W., and Warren K.G. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 14 (2008) 872-879
13. Bhan V, Brown M, Fisk J, et al. Incidence and prevalence of multiple sclerosis in Nova Scotia. Poster at American Academy of Neurology 57th Annual Meeting; Miami Beach, FL, USA; April 9-16, 2005.
14. Lim S.U., Wong W.L., Fu E., et al. The incidence of neuro-opthalmic diseases in Singapore: a prospective study in public hospitals. Ophthalmic Epidemiol 16 (2009) 65-73
15. Jin Y.P., de Pedro-Cuesta J., Söderström M., Stawiarz L., and Link H. Incidence of optic neuritis in Stockholm, Sweden 1990-1995: I. Age, sex, birth, and ethnic group-related patterns. J Neurol Sci 159 (1998) 107-114
16. Rodriguez M., Siva A., Cross S.A., O'Brien P.C., and Kurland L.T. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45 (1995) 244-250
17. D'Souza R.M. Retrospective hospital-based searches for cases of acute flaccid paralysis. Aust N Z J Public Health 26 (2001) 45-49
18. Banwell B., Kennedy J., Sadovnik D., et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 72 (2009) 232-239
19. Berman M., Feldman S., Alter M., Zilber N., and Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 31 (1981) 966-971
20. Jeffery D.R., Mandler R.N., and Davis L.E. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 50 (1993) 532-535
21. Brotherton J.M., Gold M.S., Kemp A.S., et al. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 179 (2008) 525-533
22. Bohlke K., Davis R.L., Marcy S.M., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 (2003) 815-820
23. Hauser W.A., and Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia 49 (2008) 8-12
24. Forsgren L., Sidenvall R., Blomquist H.K., and Heijbel J. A prospective incidence study of febrile convulsions. Acta Pediatr Scand 79 (1990) 550-557
25. Zeller B., Rajantie J., Hedlund-Treutiger I., et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 94 (2005) 178-184
26. Schoonen M.W., Kucera G., Coalson J., et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 145 (2009) 235-244
27. Corrado D., Basso C., Rizzoli G., Schiavon M., and Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003) 1959-1963
28. Bowker T.J., Wood D.A., Davies M.J., et al. Sudden, unexpected cardiac or unexplained death in England: a national survey. QJM 96 (2003) 269-279
29. Eckart R.E., Scoville S.L., Campbell C.L., et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141 (2004) 829-834
30. WHO. World health statistics 2009. Mortality and burden of disease. http://www.who.int/whosis/whostat/EN_WHS09_Table1.pdf (accessed Aug 2, 2009).
31. CDC. Pregnant women and novel influenza A (H1N1) virus: considerations for clinicians. http://www.cdc.gov/h1n1flu/clinician_pregnant.htm (accessed Aug 2, 2009).
32. Herbert D., Lucke J., and Dobson A. Pregnancy losses in young Australian women: findings from the Australian Longitudinal Study on Women's Health. Womens Health Issues 19 (2009) 21-29
33. Hemminki E., and Forssas E. Epidemiology of miscarriage and its relation to other reproductive events in Finland. Am J Obstet Gynecol 181 (1999) 396-401
34. Regan L., Braude P.R., and Trembath P.L. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 299 (1989) 541-545
35. Wilcox A.J., Treloar A.E., and Sandler D.P. Spontaneous abortion over time: comparing occurrence in two cohorts of women a generation apart. Am J Epidemiol 114 (1981) 548-553
36. Gray R.H., and Wu L.Y. Subfertility and risk of spontaneous abortion. Am J Public Health 90 (2000) 1452-1454
37. Papiernik E., and Goffinet F. Prevention of preterm births, the French experience. Clin Obstet Gynecol 47 (2004) 755-767
38. Morken N.H., Vogel I., Kallen K., et al. Reference population for international comparisons and time trend surveillance of preterm delivery proportions in three countries. BMC Womens Health 8 (2008) 16
39. Bodnar L.M., and Simhan H.N. The prevalence of preterm birth and season of conception. Paediatr Perinat Epidemiol 22 (2008) 538-545
40. Neutra R.R. Counterpoint from a cluster buster. Am J Epidemiol 132 (1990) 1-8
41. Iskander J.K., Miller E.R., and Chen R.T. The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety. Pediatr Ann 33 (2004) 599-606
42. Mullooly J., Drew L., Destefano F., Chen R., et al. Quality of HMO databases used to monitor vaccine safety. Am J Epidemiol 149 (1999) 186-194
43. McNicholas A., Galloway Y., Stehr-Green P., et al. Post marketing safety evaluation of a new group B meningococcal vaccine in New Zealand. Hum Vaccin 3 (2007) 196-204
44. Lasky T. Influenza vaccine and GBS. http://www.iom.edu/~/media/Files/Activity%20Files/PublicHealth/ImmunizationSafety/Lasky.ashx (accessed Oct 27, 2009).